Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?
University of Florida Center for Movement Disorders and Neurorestoration, Departments of Neurology and Neurosurgery, Gainesville, Florida.
Michael S
MS
Okun
Daniel
D
Weintraub
D000978:Antiparkinson Agents / Q000009:adverse effects*; D046690:Deep Brain Stimulation; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D007422:Intestines / Q000187:drug effects / Q000502:physiology; D007980:Levodopa / Q000009:adverse effects*; D010300:Parkinson Disease / Q000150:complications / Q000628:therapy
D000978:Antiparkinson Agents; D007980:Levodopa